Celiac Disease Market Size, Share and Forecast 2021-2027
The global celiac disease market is anticipated to grow significantly at a CAGR of 8.5% during the forecast period. Celiac disease is a digestive disorder in which the body has trouble absorbing nutrients such as lipids, calcium, iron, and folate. It is an autoimmune illness induced by eating gluten, which damages the small intestine's inner lining. Several diseases and conditions, including neurological abnormalities, infertility, reduced bone density, and some cancers, can be caused by the disease. People with type 1 diabetes, down syndrome, autoimmune thyroid disease, microscopic colitis, Addison's disease, and rheumatoid arthritis are at risk for this hereditary condition. Besides, the market for celiac disease therapy is predicted to rise significantly in the forecast period, owing to the development of several anti-inflammatory medications and therapeutic vaccinations that will replace or enhance a gluten-free diet.
To Request
a Sample of our Report on Celiac Disease Market: https://www.omrglobal.com/request-sample/celiac-disease-market
The organization of various awareness programs and
initiatives taken by the government in various nations for the treatment of
celiac disease is a major factor that is driving the growth of the global
celiac disease market. With such actions, the government may significantly
stimulate market growth. Furthermore, numerous funds are available for R&D
operations, which is propelling market expansion. For instance, in 2015, in
Italy, children and adults with certain symptoms are tested for celiac disease.
Diagnosed celiacs are given vouchers worth up to $168 per month to spend on
specially made gluten-free meals. Furthermore, restaurants are educated on how
to deal with celiac disease by the Italian Celiac Association and the
government. Gluten-free meals are even available at hospitals, schools, and
other public eating facilities.
(Get 15% Discount on Buying this
Report)
A
full Report of Celiac Disease Market is Available at: https://www.omrglobal.com/industry-reports/celiac-disease-market
Global Celiac Disease Market Segmentation
By Treatment Type
·
Vitamins
and Dietary (Gluten-Free) Supplements
·
Steroids
and Immunosuppressive Drugs
·
Therapeutic
Vaccines
By Diagnostic Type
·
Serologic
Test
·
Genetic
Testing
·
Small-Bowel
Biopsy
By End-User
·
Hospitals
and Diagnostics Centers
·
Research
Institutes
Regional
Analysis
North
America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the
World
Company Profiles
·
Abbott
Laboratories
·
AbbVie
Inc.
·
ADMA
Biologics, Inc.
·
Amgen Inc.
·
Bayer AG
·
Bio Rad
Laboratories, Inc.
·
BioLineRX
Ltd.
·
Boston
Scientific Corp.
·
Bristol-Myers
Squibb Co.
·
Calypso
Biotech SA
·
ChemoCentryx,
Inc.
·
Eli Lilly
And Co.
·
GlaxoSmithKline
plc
·
ImmunogenX,
Inc.
·
Janssen
Pharmaceuticals, Inc.
·
Johnson
& Johnson Services Inc.,
·
Merck
& Co., Inc.,
·
Sanofi S.A
·
Thermo
Fisher Scientific Inc.
·
ZEDIRA
GmbH
Reasons to buy from us –
1.
We cover more than 15 major industries, further segmented into more than
90 sectors.
2.
More than 120 countries are for analysis.
3.
Over 100+ paid data sources mined for investigation.
4.
Our expert research analysts answer all your questions before and after
purchasing your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/celiac-disease-market
About Orion Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment